• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy

Erstveröffentlichung
2012
Authors
Baumann, K. H.
du Bois, A.
Meier, W.
Rau, J.
Wimberger, P.
et al.
Wissenschaftlicher Artikel


Published in
Annals of Oncology ; 23 (2012), 9. - S. 2265-2271. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1093/annonc/mds003
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Subject headings
[Free subject headings]: angiogenesis inhibitor | ovarian cancer | platinum resistant | sunitinib | RECURRENT EPITHELIAL OVARIAN | ENDOTHELIAL GROWTH-FACTOR | ANTITUMOR-ACTIVITY | INTERGROUP TRIAL | CARCINOMA | PACLITAXEL | CARBOPLATIN | GUIDELINES | CISPLATIN
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement